House Committee Favorably Reported By Substitute
Summary
The bill directs any hospital, health system, clinic, or other medical facility that gets Georgia state money to give priority to pharmaceuticals manufactured in the United States, as long as those drugs are reasonably available. Exceptions are allowed for safety, shortages, emergencies, or if U.S. drugs cost substantially more. It also sets documentation, rulemaking, and enforcement procedures.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HB 1332 changes status, plus AI-powered summaries and stage predictions.
Sign up free